Navigation Links
CareFusion Prices $1.4 Billion of Senior Notes
Date:7/14/2009

SAN DIEGO, July 14 /PRNewswire/ -- CareFusion Corporation, the company that will become public from the planned spinoff of Cardinal Health's clinical and medical products businesses, today announced the pricing of its offering of $1.4 billion aggregate principal amount of senior unsecured notes. The notes consist of the following tranches:

  • $250 million aggregate principal amount of 4.125% senior notes due 2012
  • $450 million aggregate principal amount of 5.125% senior notes due 2014
  • $700 million aggregate principal amount of 6.375% senior notes due 2019

As previously announced, CareFusion plans to use the net proceeds from this offering to pay a special dividend to Cardinal Health in connection with the planned spinoff of CareFusion from Cardinal Health. Proceeds from the offering will be deposited in an escrow account to be released in connection with Cardinal Health's spinoff of CareFusion.

The senior notes will be general unsecured senior obligations of CareFusion. The senior notes will be sold to qualified institutional buyers in reliance on Rule 144A, and outside the United States in compliance with Regulation S under the Securities Act of 1933, as amended. The senior notes initially will not be registered under the Securities Act or State securities laws and may not be offered or sold by holders thereof without registration unless an exemption from such registration is available.

This announcement is not an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any state where such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

Cautions Concerning Forward-Looking Statements

This news release contains forward-looking statements addressing the planned spinoff of Cardinal Health's clinical and medical products businesses as a separate company named CareFusion Corporation, which is dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of any such spinoff and whether such spinoff will be completed as it is subject to a number of conditions. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.


'/>"/>
SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Board of Directors Approves CareFusion Spinoff
2. CareFusion to Resume Shipping Alaris(R) Infusion Products
3. CareFusion Corporation Launches International Jazz Festival Series
4. CareFusion Files Amended Form 10 Registration Statement With SEC
5. CareFusion Launches New Brand, Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety
6. CareFusion Names Robert Friel to Board of Directors
7. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
8. CareFusion Names Edward Borkowski as Chief Financial Officer
9. CareFusion Corporation Files Form 10 Registration Statement
10. European Prices of 170 Best-Selling Drugs Averaged 40 Percent Less Than U.S. Prices in 2008
11. Torchmark Prices Senior Notes Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... ... Periodontist Dr. Dan Holtzclaw in media for its creos™ line of bone regenerative ... by Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a ...
(Date:1/20/2017)... ... ... Source Vitál Apothecary, a skin and body care company dedicated to creating ... a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition Conference in ... nutritional, sports and health industries a chance to meet in private sessions with some ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... wellness products to enhance people’s everyday lives, recently attended the January ECRM Trade ... , ATP Science is known for its large range of supplements that keep ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has ... 002. The drinks have been produced in collaboration with Zlatan Ibrahimovic and have ... workout. , After a successful launch in Sweden last year, the next generation ...
(Date:1/20/2017)... ... 2017 , ... “I Forgive You”: a fine examination of how God handles sin, including ... of published author, Stephen Miller, who, for over ten long years has been waiting to ... in Trinidad and Tobago, he has been serving the Lord for over twenty years, and ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 ... USD 233.7 billion by 2025, according to a ... market is anticipated to be predominantly driven by ... resulting into the large-scale production of new and ... the influx of drugs at an unprecedented rate ...
(Date:1/19/2017)... 2017 Report Details ... Alzheimer,s Disease Therapeutics ... – our new study reveals trends, R&D progress, and ... affecting the Alzheimer,s disease therapeutics and diagnostics market. Our ... questions: - How is the Alzheimer,s disease therapeutics and ...
(Date:1/19/2017)... 19, 2017 According to a study conducted ... set to witness a CAGR of 6.5% during the forecast period ... will continue to be the leading market for cryotherapy globally during ... ... on ensuring affordable and adequate supply of gas in order to ...
Breaking Medicine Technology: